BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20969553)

  • 1. TNF inhibitors - new and old agents for rheumatoid arthritis.
    Simsek I
    Bull NYU Hosp Jt Dis; 2010; 68(3):204-10. PubMed ID: 20969553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapeutics for rheumatoid arthritis.
    Bingham CO
    Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF inhibitors for rheumatoid arthritis - a year in review.
    Simsek I
    Bull NYU Hosp Jt Dis; 2011; 69(3):220-4. PubMed ID: 22035432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis.
    Fleischmann R
    Expert Opin Biol Ther; 2010 May; 10(5):773-86. PubMed ID: 20230188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adalimumab: new preparation. Rheumatoid arthritis: no therapeutic advance.
    Prescrire Int; 2004 Oct; 13(73):171-5. PubMed ID: 15499697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tumor necrosis factor antagonism in clinical practice.
    Keystone EC
    J Rheumatol Suppl; 1999 May; 57():22-8. PubMed ID: 10328139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F; Murdaca G; Ghio M; Indiveri F
    Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of response to TNF inhibitors in rheumatoid arthritis - do we have new tools for personalized medicine?
    Simsek I
    Bull NYU Hosp Jt Dis; 2012; 70(3):187-90. PubMed ID: 23259626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
    Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF in rheumatoid arthritis: an overview.
    Radner H; Aletaha D
    Wien Med Wochenschr; 2015 Jan; 165(1-2):3-9. PubMed ID: 25651945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agents.
    Ranganathan P
    Curr Opin Mol Ther; 2008 Dec; 10(6):562-7. PubMed ID: 19051134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis.
    Murdaca G; Spanò F; Puppo F
    Expert Opin Drug Saf; 2013 Nov; 12(6):801-4. PubMed ID: 23889669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF therapy: safety aspects of taking the risk.
    Rosenblum H; Amital H
    Autoimmun Rev; 2011 Jul; 10(9):563-8. PubMed ID: 21570495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M
    J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2005 Jan; 72():46-7. PubMed ID: 15660467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor inhibitors: new options for treating rheumatoid arthritis.
    Moreland LW
    Isr Med Assoc J; 2001 Sep; 3(9):686-90. PubMed ID: 11574988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study.
    Lee SJ; Chang H; Yazici Y; Greenberg JD; Kremer JM; Kavanaugh A
    J Rheumatol; 2009 Aug; 36(8):1611-7. PubMed ID: 19369454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TNF inhibitors].
    Kameda H
    Nihon Rinsho; 2016 Jun; 74(6):957-62. PubMed ID: 27311185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.